150 related articles for article (PubMed ID: 31205550)
1. Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.
Liu J; Min L; Zhu S; Guo Q; Li H; Zhang Z; Zhao Y; Xu C; Zhang S
J Cancer; 2019; 10(8):1915-1922. PubMed ID: 31205550
[No Abstract] [Full Text] [Related]
2. CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.
Yu H; Yao J; Du M; Ye J; He X; Yin L
Oncol Lett; 2020 Jan; 19(1):542-548. PubMed ID: 31897169
[TBL] [Abstract][Full Text] [Related]
3. [FAT1 inhibits cell proliferation of esophageal squamous cell carcinoma through regulating the expression of CDK4/CDK6/CCND1 complex].
Hu XL; Zhai YF; Li GD; Xing JF; Yang J; Bi YH; Wang J; Shi RY
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):14-20. PubMed ID: 29365412
[No Abstract] [Full Text] [Related]
4. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
5. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
Wang H; Chen H; Zhou H; Yu W; Lu Z
Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
[TBL] [Abstract][Full Text] [Related]
6.
Zhang Y; Miao Y; Shang M; Liu M; Liu R; Pan E; Pu Y; Yin L
Cancer Manag Res; 2019; 11():6201-6214. PubMed ID: 31308755
[No Abstract] [Full Text] [Related]
7. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion].
Xu H; Meng XR; Zhou Y; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):105-113. PubMed ID: 32135643
[No Abstract] [Full Text] [Related]
8. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
[TBL] [Abstract][Full Text] [Related]
9. Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells.
Zou N; Zhang X; Li S; Li Y; Zhao Y; Yang X; Zhu S
J Cancer; 2021; 12(16):5013-5024. PubMed ID: 34234870
[No Abstract] [Full Text] [Related]
10. Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Ke K; Sun Z; Wang Z
Oncol Lett; 2018 Aug; 16(2):1801-1808. PubMed ID: 30008868
[TBL] [Abstract][Full Text] [Related]
11. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.
Ke Y; Guo W; Huang S; Li Y; Guo Y; Liu X; Jin Y; Ma H
Life Sci; 2020 Jun; 250():117578. PubMed ID: 32209426
[TBL] [Abstract][Full Text] [Related]
12. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
Dai W; Miao H; Fang S; Fang T; Chen N; Li M
Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of the suppression of proliferation and invasion ability mediated by microRNA-147b in esophageal squamous cell carcinoma].
Tang Y; Li Z; Shi ZX
Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(26):2092-2098. PubMed ID: 30032507
[No Abstract] [Full Text] [Related]
14. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
15. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
16. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
17. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
18. [Effect of downregulation of Tiam1 by siRNA on esophageal squamous cell carcinoma EC9706 cells].
Liu H; Jiang L; Liu X
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):250-6. PubMed ID: 24989909
[TBL] [Abstract][Full Text] [Related]
19. ACTL6A Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells and Correlates with Poor Clinical Outcomes.
Li RZ; Li YY; Qin H; Li SS
Onco Targets Ther; 2021; 14():199-211. PubMed ID: 33469301
[TBL] [Abstract][Full Text] [Related]
20. Effects of down-regulation of HDAC6 expression on proliferation, cell cycling and migration of esophageal squamous cell carcinoma cells and related molecular mechanisms.
Li N; Tie XJ; Liu PJ; Zhang Y; Ren HZ; Gao X; Xu ZQ
Asian Pac J Cancer Prev; 2013; 14(2):685-9. PubMed ID: 23621219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
